Last reviewed · How we verify
Placebo - first 24 weeks — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo - first 24 weeks (Placebo - first 24 weeks) — University of Alabama at Birmingham. Placebo has no active pharmacological mechanism; it serves as a control comparator in clinical trials.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo - first 24 weeks TARGET | Placebo - first 24 weeks | University of Alabama at Birmingham | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo - first 24 weeks CI watch — RSS
- Placebo - first 24 weeks CI watch — Atom
- Placebo - first 24 weeks CI watch — JSON
- Placebo - first 24 weeks alone — RSS
Cite this brief
Drug Landscape (2026). Placebo - first 24 weeks — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-first-24-weeks. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing